IQVIA Holdings Inc.
IQV
Pozycja w akcjach
#560
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical... IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
Cena akcji
$266.90
Ostatnia synchronizacja: 2026-10-16
Kapitalizacja rynkowa
$43.93B
Zmiana (1 dzień)
-1.32%
Zmiana (1 rok)
30.48%
Kraj
US
Handel IQVIA Holdings Inc. (IQV)
Kategoria
Healthcare
Marża operacyjna dla IQVIA Holdings Inc. (IQV)
Marża operacyjna na dzień October 2026 TTM: 13.57%
Według najnowszych raportów finansowych i ceny akcji IQVIA Holdings Inc., bieżąca marża operacyjna (TTM) wynosi 13.57%. Na koniec 2024 wynosiła 14.29%.
Historia marży operacyjnej dla IQVIA Holdings Inc. od 2010 do 2026
Marża operacyjna na koniec każdego roku
| Rok | Marża operacyjna | Zmień |
|---|---|---|
| 2026 (TTM) | 13.57% | -3.21% |
| 2025 | 14.02% | -1.89% |
| 2024 | 14.29% | 8.34% |
| 2023 | 13.19% | 5.69% |
| 2022 | 12.48% | 24.30% |
| 2021 | 10.04% | 55.90% |
| 2020 | 6.44% | -8.13% |
| 2019 | 7.01% | -1.54% |
| 2018 | 7.12% | -3.91% |
| 2017 | 7.41% | -21.34% |
| 2016 | 9.42% | -16.42% |
| 2015 | 11.27% | 4.26% |
| 2014 | 10.81% | 19.18% |
| 2013 | 9.07% | 11.29% |
| 2012 | 8.15% | 2.13% |
| 2011 | 7.98% | -20.75% |
| 2010 | 10.07% | 0.00% |
Marża operacyjna dla podobnych firm lub konkurentów
| Firma | Marża operacyjna | Różnica w marży operacyjnej | Kraj |
|---|---|---|---|
| 17.97% | -98.68% |
US
|
|
| 20.42% | -98.50% |
US
|
|
| -10.70% | -100.79% |
US
|
|
| 0.00% | - |
CN
|
|
| 22.23% | -98.36% |
US
|
Czym jest marża operacyjna firmy?
Marża operacyjna to kluczowy wskaźnik do oceny rentowności firmy. Wyższe marże operacyjne są zazwyczaj korzystniejsze, ponieważ pokazują, że firma może sprzedawać swoje produkty lub usługi znacznie drożej niż koszty ich produkcji. Oblicza się ją, dzieląc zysk firmy przez jej przychody.